Neutra prepares new technology to make cannabis reliable cash crop in desert

NewsGuard 100/100 Score

Neutra Corp. (OTCBB: NTRR) is preparing new technology for the marketplace designed to help make cannabis a reliable cash crop—even in the desert.

Dale Devitt, a professor at UNLV, recently told the Las Vegas Review-Journal that medical cannabis' high retail price and relatively low water requirements will put it ahead of alfalfa farming and even golf course operations in terms of profitability per acre-foot of water in the arid state of Nevada.

Alfalfa earns $100 profit per acre-foot of water, while golf courses earn $5,000-$7,000 per acre-foot of water. Devitt did not offer a profit figure for cannabis cultivation but claimed the plant's high value would "justify the use of water in the desert."

Terra Tech, a firm that has applied for a cultivation license in Clark County, Nev., estimates it can produce 75 pounds of marijuana each week at its 50,000 square-foot facility: an annual yield between $15 million to $25 million in annual sales. NTRR believes there are millions more to be made in supplying new technology to growers.

NTRR is working to assist partner Vertigo Technologies in delivering a turn-key solution for indoor horticulturalists that could be especially useful for growers in Nevada and other booming horticultural markets for whom high yields and speedy production are especially crucial to business. Additionally, the partners are developing anti-microbial solutions that could one day eliminate the need for pesticides in the herb's cultivation.

"Cultivation is being honed into a science by entrepreneurs who want to be able to compete," said NTRR CEO Sydney Jim. "We want to supply the instruments for this new science."

Source:

Neutra Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses